title: Bone-targeted therapies for cancer patients and bone cell biology: where do we stand?
authors.affiliation: aOncotherapeutics bInstitute for Myeloma and Bone Cancer Research cJames R. Berenson, MD, Inc., West Hollywood, California, USA.
authors.forename: James R
authors.initials: JR
authors.lastname: Berenson
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000556:secondary*; D001842:Bone and Bones / Q000502:physiology; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates